Esther Yankey, APRN
Psychiatry · Crystal, MNNPI 1053019836
Payments from drug & device makers
Across 13 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$46
- E.r. Squibb & Sons, L.L.C.$35
- Teva Pharmaceuticals USA, Inc.$35
- AbbVie$32
- Axsome Therapeutics, Inc.$15
- Otsuka America Pharmaceutical, Inc.$14
- plus $28 from 2 others
What the payments were for
- Food & beverage$206100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 3 | $46 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| AbbVie | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
How this compares
$206 in reported general payments places this provider in the 80th percentile of 552 psychiatry providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 16 | $122,724 |
| Invega SustennaPaliperidone Palmitate | 36 | $118,124 |
| Risperidone ErRisperidone Microspheres | 32 | $40,084 |
| Lurasidone Hcl | 63 | $5,616 |
| Olanzapine | 116 | $3,747 |
| Quetiapine Fumarate | 120 | $3,477 |
| Aripiprazole | 51 | $2,943 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 25 | $2,869 |
| Hydroxyzine Hcl | 93 | $2,397 |
| Clozapine | 63 | $2,260 |
| Haloperidol | 86 | $2,079 |
| Risperidone | 123 | $2,051 |
| Bupropion XlBupropion Hcl | 58 | $1,841 |
| Trazodone Hcl | 142 | $1,804 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 44 | $1,779 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Crystal
- William NelsonCrystal$5K
- Ziad NahasMinneapolis$732K
- Sujit VarmaEdina$581K
- Michael FarnsworthMankato$548K
- Danielle Magness-WellmannMankato$308K
- John LuehrMinnetonka$154K
- Craig VineSt Paul$136K
- Alik WidgeMinneapolis$96K
- Thomas WinegardenChanhassen$55K
- Raymond AugerRochester$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.